Summary and opinion by Wendy Anderson.
Lawmakers have received a signed letter from the heads of the DEA, the Department of Health and Human Services, and the Office of National Drug Control Policy. The content of this letter includes statements that they have been presented with scientific and medical evaluations and a scheduling recommendation from the HHS. It says they hope to release a determination on rescheduling “in the first half of 2016."
Cannabis is in the progress of being reduced from a schedule I drug in order to make it easier to for scientific research and more wider medicinal uses.
Advocates against rescheduling are against legalizing the entire drug, saying that it’s a step too far and would rather the DEA should just legalize the cannabinoid compounds of the plant.
Rescheduling Cannabis has been rejected before, however, since the last petition many more researchers and important groups have come forward to support rescheduling. Those include The American Academy of Pediatrics and The Epilepsy Foundation of America.
Read the original article here.
Comments will be approved before showing up.
Liquid error: Could not find asset snippets/mailchimp-popup.liquid